MiniMed Group, Inc. Common Stock
NASDAQ:MMEDMedical - Care Facilities
+$0.40 today
- Market cap
- $4.78B
- Beta
- -3.63
- P/E (TTM)
- -14.2
- EPS (TTM)
- -$1.91
Volume 4.70M
Average 0.95M
MMED Depreciation & Amortization
Non-cash asset write-downs added back to net income because no cash left the business.
MiniMed Group, Inc. Common StockNASDAQ: MMED
Depreciation & Amortization · Q1 FY2026 · quarter ended Jul 2026
Depreciation & amortization of $41M in Q1 FY2026
Q1 FY2026 depreciation & amortization was $41M. Trailing-twelve-month depreciation & amortization was $158M. Over 3 fiscal years it compounded at +10.7% a year.
Context
- Depreciation & amortization amounted to 5.0% of revenue in FY2025, down 0.2 pp from a year earlier.
- Depreciation & amortization increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly depreciation & amortization holds near $41M or moves back toward the trailing-twelve-month quarterly average of $39.5M.
Sources:Cash FlowText generated from reported figures; not investment advice.
Depreciation & Amortization history
USD · from the cash flow
- Latest · FY2025
- 156M USD
- Year-over-year change
- +9.1%
- 3-year CAGR
- +10.7%
| Period | Period end | Depreciation & Amortization | YoY change |
|---|---|---|---|
| FY2025 | 2026-04-24 | 156M | +9.1% |
| FY2024 | 2025-04-30 | 143M | +10.9% |
| FY2023 | 2024-04-30 | 129M | +12.2% |
| FY2022 | 2023-04-30 | 115M | — |
Depreciation & Amortization vs competitors
How MMED compares with its peers on the latest reported figures
- MMED's LTM Jul 2026 depreciation & amortization of $158M is the 3rd largest of the 7 companies compared; the peer median is $58.21M.
- Depreciation & amortization amounts to 4.9% of revenue for MMED, versus a peer median of 3.4%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jul 2026 | $2.85B | -3.4% | +3.1% | 7.6% | |
| LTM Jun 2026 | $264.1M | +11.9% | +17.3% | 5.3% | |
MMEDMiniMed Group, Inc. Common Stock | LTM Jul 2026 | $158M | — | +10.7% | 4.9% |
| LTM Jun 2026 | $99.3M | +14.4% | +12.7% | 3.3% | |
| LTM Mar 2026 | $17.11M | -1.1% | -1.2% | 1.7% | |
| LTM Mar 2026 | $2.94M | +26.6% | +11.3% | 2.7% | |
| LTM Mar 2026 | $1.48M | +102.1% | -54.8% | 3.6% | |
MMEDVMiniMed Group, Inc. | — | — | — | — | — |
| Peer median (excluding MMED) | $58.21M | +13.1% | +7.2% | 3.4% | |
Competitors are the stored peer set for MMED. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2022 Apr 2023 | FY2023 Apr 2024 | FY2024 Apr 2025 | FY2025 Apr 2026 |
|---|---|---|---|---|
| Net Income | (92M) | (107M) | (198M) | (317M) |
| Depreciation & Amortization | 115M | 129M | 143M | 156M |
| Deferred Income Tax | (11M) | 3M | (2M) | (54M) |
| Stock-Based Compensation | 35M | 38M | 41M | 46M |
| Change in Working Capital | (90M) | (74M) | 122M | (166M) |
| Accounts Receivables | (70M) | (105M) | (66M) | (538M) |
| Inventory | (28M) | 5M | (19M) | (29M) |
| Accounts Payables | 14M | (4M) | 191M | 41M |
| Other Working Capital | (6M) | 30M | 16M | 360M |
| Other Non-Cash Items | 37M | 52M | 34M | 138M |
| Operating Cash Flow | (6M) | 41M | 140M | (197M) |
| Capital Expenditures | (167M) | (148M) | (193M) | (223M) |
| Acquisitions (Net) | 0 | 0 | 0 | 0 |
| Purchases of Investments | (13M) | (5M) | 0 | 0 |
| Sales of Investments | 0 | 11M | 0 | 0 |
| Other Investing Activities | 0 | (15M) | 0 | (10M) |
| Investing Cash Flow | (180M) | (157M) | (193M) | (233M) |
| Debt Repayment | 0 | 0 | 0 | 0 |
| Common Stock Issued | 0 | 0 | 0 | 538M |
| Common Stock Repurchased | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 |
| Other Financing Activities | 185M | 112M | 10M | 178M |
| Financing Cash Flow | 185M | 112M | 10M | 716M |
| Effect of Forex Changes | 0 | 0 | 0 | 1M |
| Net Change in Cash | (2M) | (4M) | (43M) | 287M |
| Free Cash Flow | (173M) | (107M) | (53M) | (420M) |
MiniMed Group, Inc. Common Stock
NASDAQ:MMED
Intrinsic Alpha fair value
Locked
Current Price
$16.99
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.